Αρχική World News Osteosarcoma: first progress in decades with an antibody–drug conjugate World News Osteosarcoma: first progress in decades with an antibody–drug conjugate Από Ogkologos - 26 Οκτωβρίου, 2026 9 0 Facebook Twitter Google+ Pinterest WhatsApp Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Radiotherapy Can Be Safely Omitted in Older Women with Low-Risk, HR-positive... 24 Φεβρουαρίου, 2023 Superior Prognostic Accuracy of Integrated 15-GEP/PRAME Classifier Over 15-GEP Alone in... 22 Αυγούστου, 2024 Ahead of a Key Meeting of EU Health Ministers, ESMO Calls... 14 Ιουνίου, 2026 FDA Authorizes Blood Test for Assessing Risk of Hereditary Cancers 2 Νοεμβρίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Colonoscopy after Positive FIT Test Cuts Risk of Colorectal Cancer Death When Both Tumour-Infiltrating Lymphocytes and Gene Expression are Available, the Prognostic... What’s happened to cancer clinical trials during the COVID-19 pandemic? CVS, Walgreens, Rite Aid Suspend Sales Of Zantac Following Cancer-Causing Concerns
